NAMWISE’s cover photo
NAMWISE

NAMWISE

Biotechnology Research

NAMWISE - NAMs Within Integrated Safety & Efficacy evaluation of chemicals and pharmaceuticals

About us

NAMWISE project aims to drive the adoption and integration of New Approach Methodologies (NAMs) for the assessment of the safety and efficacy of chemicals and pharmaceuticals. By providing a comprehensive set of recommendations, guidance, and training resources, NAMWISE seeks to validate and implement NAMs effectively. The project adopts a definition of NAMs that excludes vertebrate-based data and models, focusing on in vitro approaches (including organoids and organ-on-chips), in silico methods, Adverse Outcome Pathways (AOP), and Integrated Approaches to Testing and Assessment (IATA).

Website
namwise.eu
Industry
Biotechnology Research
Company size
11-50 employees
Type
Nonprofit
Specialties
New Approach Methodologies, Pharmaceutical Industry, Chemical Industry, Animal-Free Testing, Regulatory Acceptance, Validation & Standardization, and Public Awareness & Scientific Education

Employees at NAMWISE

Updates

Similar pages